ValiRx PLC to present at leading US cancer conference
The American Association for Cancer Research Annual Conference will take place in New Orleans, starting April 16.
Company
LON:VAL
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.
310 stories · page 14 of 16
The American Association for Cancer Research Annual Conference will take place in New Orleans, starting April 16.
Petroleum plays Bankers Petroleum and Bahamas Petroleum were the highlights of the small-caps scene
Major share price risers and fallers in London at 4.15pm
The agreement will see Bracknor subscribe for the convertible loan notes in eight equal tranches of £0.5mln
Archive
Sirius Minerals' "world class" North Yorkshire project, update on Aureus and Allergy Therapeutics to lose finance director.
The Bank of England kept interest rates unchanged for the 84th month in a row.
Small cap shares were heading south in contrast to bigger brother FTSE100 but tech group Sopheon PLC was a notable riser.
Burns McClellan has already carried out an institutional investor introductory project for ValiRx.
ValiRx has one drug, VAL201, going through phase I/II trials
Below are the main news-driven share price changes at 1.00pm.
Archive
Specialist security group Westminster saw shares advance as cargo screening operations began at Freetown International Airport (FNA) in Sierra Leone, West Africa.
Those of you who dumped shares of cyber-security group Sophos ahead of today's trading update: good call!
VAL201 is currently going through a phase I/II trial for prostate cancer treatment.
Archive
Highlights of the news developments from the growth companies universe
Next steps will be a trial expansion phase, which will include centres in addition to UCH in London.
Archive
There were some fireworks at Proactive today... Alliance Pharma shares nudged higher on Thursday after it emerged it will receive £6.7mln in compensation.....
New office will also position it in close proximity to the biggest biotech market in the world.